Fusion Pharmaceuticals Inc. Quarterly Operating Margin in % from Q4 2022 to Q4 2023

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Fusion Pharmaceuticals Inc. quarterly/annual Operating Margin history and growth rate from Q4 2022 to Q4 2023.
  • Fusion Pharmaceuticals Inc. Operating Margin for the quarter ending December 31, 2023 was -4.8K %, a 20.4% increase year-over-year.
  • Fusion Pharmaceuticals Inc. annual Operating Margin for 2023 was -4.8K %, a 20.4% increase from 2022.
  • Fusion Pharmaceuticals Inc. annual Operating Margin for 2022 was -6.03K %, a 5.8% decline from 2021.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q4 2023 -4.8K +1.23K +20.4% Oct 1, 2023 Dec 31, 2023
Q3 2023 -4.32K Jul 1, 2023 Sep 30, 2023
Q2 2023 -27.1K Apr 1, 2023 Jun 30, 2023
Q1 2023 -10.2K Jan 1, 2023 Mar 31, 2023
Q4 2022 -6.03K Oct 1, 2022 Dec 31, 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.